<DOC>
	<DOCNO>NCT02972125</DOCNO>
	<brief_summary>This study design demonstrate Bioequivalence Lacosamide ( LCM ) Tablet Dry Syrup Healthy Male Japanese Subjects</brief_summary>
	<brief_title>A Study Demonstrate Bioequivalence Lacosamide Tablets Dry Syrup Healthy Male Japanese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Lacosamide</mesh_term>
	<criteria>Subject male 20 55 year age ( inclusive ) Subject Japanese descent evidence appearance verbal confirmation familial heritage ( subject 4 Japanese grandparent born Japan ) Male subject confirms sexual intercourse woman childbearing potential , use condom study 1 week last dose study drug Subject medical psychiatric condition , opinion investigator , could jeopardize would compromise subject 's ability participate study . Subject clinically relevant outofrange value hematology , serum chemistry , urinalysis variable Screening Visit . Subject clinically significant abnormal physical examination ( Screening Visit Day 1 ) vital sign ( Screening Visit ) . Subject clinically relevant ECG find Screening Visit .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Lacosamide</keyword>
	<keyword>Bioequivalence</keyword>
	<keyword>Dry Syrup</keyword>
</DOC>